View in EDS HTML Full Text PDF Full Text

An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.

Saved in:
Bibliographic Details
Title: An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
Authors: Dailey, Kaitlin M.1,2,3 (AUTHOR) kadailey@unmc.edu, Small, James M.4 (AUTHOR), Pullan, Jessica E.3,5 (AUTHOR), Winfree, Seth1,6 (AUTHOR), Vance, Krysten E.1 (AUTHOR), Orr, Megan7,8 (AUTHOR), Mallik, Sanku2,3 (AUTHOR), Bayles, Kenneth W.6 (AUTHOR), Hollingsworth, Michael A.1 (AUTHOR), Brooks, Amanda E.2,3,9 (AUTHOR)
Source: PLoS ONE. 11/14/2023, Vol. 18 Issue 11, p1-25. 25p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0289183